cytarabine has been researched along with arginyl-glycyl-aspartic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Contino-Pépin, C; Jasseron, S; Maurizis, JC; Pucci, B; Rapp, M | 1 |
| Cui, C; Cui, G; Liu, H; Ren, Z; Wang, F; Wang, L | 1 |
2 other study(ies) available for cytarabine and arginyl-glycyl-aspartic acid
| Article | Year |
|---|---|
In vitro and in vivo evaluations of THAM derived telomers bearing RGD and Ara-C for tumour neovasculature targeting.
Topics: Acrylates; Animals; Cell Division; Cell Line, Tumor; Cytarabine; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Male; Methylamines; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Oligopeptides; Prodrugs; Tissue Distribution | 2003 |
Preparation and biological evaluation of tumor-specific Ara-C liposomal preparations containing RGDV motif.
Topics: Animals; Antimetabolites, Antineoplastic; Cytarabine; Drug Delivery Systems; Liposomes; Male; Mice; Oligopeptides; Sarcoma 180 | 2012 |